Does RAMIPRIL Cause Salivary hypersecretion? 51 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Salivary hypersecretion have been filed in association with RAMIPRIL (Ramipril). This represents 0.2% of all adverse event reports for RAMIPRIL.
51
Reports of Salivary hypersecretion with RAMIPRIL
0.2%
of all RAMIPRIL reports
0
Deaths
12
Hospitalizations
How Dangerous Is Salivary hypersecretion From RAMIPRIL?
Of the 51 reports, 12 (23.5%) required hospitalization, and 10 (19.6%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMIPRIL. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does RAMIPRIL Cause?
Acute kidney injury (3,286)
Dyspnoea (2,537)
Dizziness (2,490)
Hypotension (2,417)
Fatigue (2,415)
Drug ineffective (2,412)
Nausea (2,219)
Vomiting (2,055)
Off label use (2,053)
Hypertension (2,046)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which RAMIPRIL Alternatives Have Lower Salivary hypersecretion Risk?
RAMIPRIL vs RAMUCIRUMAB
RAMIPRIL vs RANEXA
RAMIPRIL vs RANIBIZUMAB
RAMIPRIL vs RANIMUSTINE
RAMIPRIL vs RANITIDINE